Explore more publications!

FilmIQ Launches The White List

A New Standard for Identifying Execution-Ready Screenplays

LOS ANGELES, CA, UNITED STATES, January 23, 2026 /EINPresswire.com/ -- FilmIQ™ today announced the launch of The White List, a curated list of unproduced screenplays that have met a measurable standard of execution, benchmarked against patterns discovered researching thousands of produced films.

Unlike traditional screenplay lists that rely on executive surveys, nominations, or popularity-based voting, The White List is built on FilmIQ’s proprietary knowledge base, data set and grading system developed in collaboration with NoQueryLetter.com™.

Scripts earn placement on The White List by scoring above a defined quality threshold. Placement indicates that a screenplay has passed a rigorous executional benchmark and is cleared for consideration by FilmIQ and its production partners for funding, development, or packaging.

“The industry doesn’t have a talent problem; it has a filtering problem. Who has the time and staff to read it all?” said a FilmIQ spokesperson. “The White List exists to reduce noise, remove bias, and ensure that execution-ready material gets fast-tracked.”

The White List is not a contest, a prediction of taste or genre trends. It functions as a clearance system allowing qualified screenplays to bypass traditional gatekeeping mechanisms and reach decision-makers more efficiently.

The list will be updated on a recurring basis, with major releases announced publicly and interim updates reflected within the FilmIQ platform. FilmIQ plans to release a white paper on its research findings in the fourth quarter.

About FilmIQ
FilmIQ is a data-driven film finance and development company focused on improving decision-making in the entertainment industry through scalable analysis of story execution. For more information, visit: FilmIQ.io

Press Contact:

Betty
FilmIQ
pr@filmiq.io
Visit us on social media:
LinkedIn
Facebook
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions